Every day since Anteis was founded in 2003, I’ve talked to employees, scientific, financial and commercial partners, doctors, surgeons, patients… and all of them say the same thing:
“It’s a great adventure!”
That Anteis story can create so much enthusiasm shouldn’t surprise anyone. The company came out of the determination of men and women specialized in their field (biopolymer transformation) who saw the development potential and wanted patients to benefit from the best that innovation had to offer. Just two years after it was created, Anteis launched a first range of medical devices for the aesthetic dermatology market. One innovation followed another and our company has been proposing, each and every year, new solutions to doctors and surgeons throughout the world.
Our company has developed, in not quite three years, a distribution network and has gotten a strong foothold in over 85 countries around the world. Licensing agreements have allowed us to cover other even larger geographical areas and will open up the North American market to us by the end of 2010.
We’ve been able to meet these scientific, technical, commercial and financial challenges without losing sight of our essential values.
We’re proud to say that the honours Anteis has received reward our scientific teams’ know-how as much as our innovative developments.
There’s no doubt about it: it’s a great adventure!
And it’s only just started…
That Anteis story can create so much enthusiasm shouldn’t surprise anyone. The company came out of the determination of men and women specialized in their field (biopolymer transformation) who saw the development potential and wanted patients to benefit from the best that innovation had to offer. Just two years after it was created, Anteis launched a first range of medical devices for the aesthetic dermatology market. One innovation followed another and our company has been proposing, each and every year, new solutions to doctors and surgeons throughout the world.
Our company has developed, in not quite three years, a distribution network and has gotten a strong foothold in over 85 countries around the world. Licensing agreements have allowed us to cover other even larger geographical areas and will open up the North American market to us by the end of 2010.
We’ve been able to meet these scientific, technical, commercial and financial challenges without losing sight of our essential values.
We’re proud to say that the honours Anteis has received reward our scientific teams’ know-how as much as our innovative developments.
There’s no doubt about it: it’s a great adventure!
And it’s only just started…
recommendprint this page top
